Questionnaire-based characterization of bronchial asthma in the elderly: Analysis in Niigata Prefecture, Japan  by Suzuki, Eiichi et al.
Allergology International
 
 (2002) 
 
51
 
: 241–248
 
Original Article
 
Questionnaire-based characterization of bronchial 
asthma in the elderly:  Analysis in Niigata Prefecture, 
Japan
 
Eiichi Suzuki,
 
1
 
 Takashi Hasegawa,
 
1
 
 Toshiyuki Koya,
 
1
 
 Ichiro Mashima,
 
1
 
 Yoshiyuki 
Muramatsu,
 
1
 
 Ariyoshi Kondo,
 
2
 
 Masaaki Arakawa
 
1
 
 and Fumitake Gejyo
 
1
 
1
 
Division of Respiratory Medicine, Niigata University Graduate School of Medical and Dental Sciences, and 
 
2
 
Niigata Asthma Treatment Study Group, Niigata, Japan
 
A
 
BSTRACT
Background:
 
Because the mean lifespan is increasing
and the percentage of elderly people among the
population as a whole is  also increasing, the manage-
ment of elderly bronchial asthma patients will be an
important issue in medicine in the future. In the present
study,  based on questionnaires given to 3224 asth-
matic patients in Niigata Prefecture, the characteristics,
management and circumstances of elderly asthmatic
patients were investigated.
 
Methods:
 
Questionnaires were completed by asth-
matic patients and their physicians in participating
institutions  within Niigata Prefecture from September
to October 1999. Patients more than 65 years of age
were defined as elderly asthmatic patients and a com-
parison was made between these patients and younger
asthmatic patients who were less than 64 years of age
and    were used as a control group.
 
Results:
 
In the classification of bronchial asthma, a
greater frequency of infectious and mixed-type bron-
chial  asthma was found in the elderly, whereas the
use of peak flow meters was lower in this group.
Significant differences were found for both self-
evaluation of the condition of the asthma and satis-
faction with daily life between the two age groups. A
lower incidence of ambulance use, emergency room
visits and use of inhaled steroids was observed in
elderly patients, although the incidence of hospital-
ization and use of oral steroids was higher. The dis-
crepancy   between objective and subjective evaluation
of asthma control, the incidence of the use of both
inhaled and oral steroids and the low use of peak flow
meters were problematic in the elderly.
 
Conclusions:
 
Based on sufficient consideration of
the problems specifically related to elderly asthmatic
patients, adequate education and careful manage-
ment of asthma in this group are required, and the
accumulation of these steps will result in the achieve-
ment of the guidelines final goals.
 
Key words:
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I
 
NTRODUCTION
 
At the end of the 19th century, the number of people
over 65 years of age was below 15 million worldwide,
less than 1% of the whole population. Now, people over
65 years of age represent 6.2% of the world’s popula-
tion. Therefore, the characteristics of some diseases in
elderly people require reconsideration compared with
younger people, including diagnosis and therapy.
Bronchial asthma had been considered a rare disease
in elderly patients because of its infrequent onset at this
age, although it is a common disorder for respiratory
physicians. However, several studies have shown that
bronchial asthma in the elderly is not so uncommon.
 
1–3
 
Despite the characteristics of elderly asthma reported in
several papers, these cases seem to be very complex.
 
4
 
The present study attempts to identify the actual state
of bronchial asthma in the elderly. To achieve this, a
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questionnaire-based investigation was conducted among
patients with bronchial asthma and their physicians
in cooperation with a number of medical institutions in
Niigata Prefecture, Japan. Management for elderly
asthmatic patients should be performed under current
guidelines.
 
5,6
 
M
 
ETHODS
 
Through questionnaires, patients with adult bronchial
asthma who visited the participating institutions were
asked their age, duration and onset age of asthma and
their asthmatic symptoms in the 2 week period prior
to the questionnaire, as well as the usage status of a
peak flow meter. The questionnaires also inquired about
asthma-related episodes, including ambulance use, emer-
gency room visits, hospitalization, anti-inflammatory
agent-induced asthma attacks (aspirin-induced asthma;
AIA), unconsciousness during asthma attacks and man-
agement of asthma using a respirator. The questionnaire
was administered to patients over a period of 2 months,
from September to October 1999. At the same time,
the patients’ physicians answered questionnaires inves-
tigating the severity of asthma and the details of treat-
ment. The investigation involved 153 institutions around
Niigata Prefecture and information was collected on
3224 cases. The general profile of cases with asthma
was understood. In this investigation, patients greater
than 65 years of age were defined as elderly asthmatic
patients (EAP; 
 
n
 
 = 1084). After obtaining and analyzing
these results, a comparison was made between EAP and
younger asthmatic patients (YAP; 
 
n
 
 = 2114) as a control
group, who were aged less than 64 years.
Student’s 
 
t
 
-test and the 
 
χ
 
2
 
-test were performed to
compare EPA and YPA. 
 
P
 
 < 0.001 was considered sig-
nificant.
 
R
 
ESULTS
 
Patient background
 
The baseline characteristics of EAP and YAP are sum-
marized in Table 1. The mean (
 
±
 
SD) age, gender ratio
(males/females) and duration of asthma in EAP and YAP
were 72.1 
 
±
 
 5.5 versus 44.5 
 
±
 
 14.0 years, 1.25 versus
0.94 and 11.8 
 
±
 
 13.4 versus 10.4 
 
±
 
 11.0 years, res-
pectively. Significant differences were found in age and
gender between EAP and YAP. The physicians in charge
graded disease type and severity. The rates of atopic,
mixed-type and infectious disease, given as percentages,
in EAP and YAP were 16.8 versus 49.6%, 38.6 versus
27.5% and 41.6 versus 20.5%, respectively, indicating
that the rate of infectious-type disease in EAP was
significantly higher than in YAP (
 
P
 
 < 0.0001). The rates
of mixed- and atopic-type disease were lower
(
 
P
 
 < 0.0001). As for the severity of the disease, the rates
of mild, moderate and severe cases in EAP and YAP,
given as a percentage, were 43.0 versus 45.3%, 43.0
versus 44.3% and 12.4 versus 8.7%, respectively. No
significant differences were found for severity of disease.
Although the use of a peak flow meter is strongly
recommended in the guidelines for controlling asthma,
 
5,6
 
such meters were used by 28.5% of EAP, which was
 
Table 1
 
Baseline characteristics of the patients
EAP YAP
 
P
 
No. patients 1084 2116
Age (years) 72.1 ± 5.5 44.5 ± 14.0 0.0001
Duration of asthma (years) 11.8 ± 13.4 10.4 ± 11.0 0.0010
Gender (males/females) 602/482 1026/1090 0.0002
Use of peak-flow meter (%) 28.5 38.3 0.0001
Classification
Atopic (%) 16.7 49.6 0.0001
Mixed (%) 38.6 27.5 0.0001
Infectious (%) 41.6 20.5 0.0001
Severity
Mild (%) 43.0 45.3 0.2375
Moderate (%) 43.0 44.3 0.5172
Severe (%) 12.4 8.7 0.0010
 
Where appropriate, data are given as the mean ±SD.
EAP, elderly asthmatic patients; YAP, young asthmatic patients.
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significantly lower (P < 0.0001) than the rate of use
by YAP.
For EAP who used a peak flow meter, the peak expira-
tory flow rate (PEF) value, as a percentage of predicted
PEF values (%PEF), was 73.1 ± 23.0% in the early
morning and 76.7 ± 22.4% at night, which was signifi-
cantly lower (P < 0.0001) than the figures obtained for
YAP users of the peak flow meter (80.0 ± 17.8 and
82.5 ± 17.8%, respectively; Fig. 1).
Asthma attacks during the 2 weeks prior to 
answering the questionnaire
To investigate the circumstances surrounding asthma
attacks, asthma attacks during the 2 weeks prior to
answering the questionnaire were analyzed based on the
information collected. The percentage of cases who did
not experience an attack was 51.0% for EAP and 58.6%
for YAP (Table 2). A significant difference was seen in
both groups (P < 0.0001). Subjects were asked to rate
the condition of their asthma during the 2 weeks prior to
the questionnaires by choosing one of five options (‘very
good’, ‘fairly good’, ‘mediocre’, ‘slightly bad’ and
‘bad’) in order to subjectively evaluate asthma control
from the patients’ viewpoint. The percentage responses
for each of the five levels of ‘very good’, ‘fairly good’,
‘mediocre’, ‘slightly bad’ and ‘bad’ were 16.7, 34.5,
33.9, 10.6 and 2.9%, respectively, for EAP and 18.4,
34.9, 25.4, 17.1 and 3.6%, respectively, for YAP
(Table 2). Significant differences were found for the
‘mediocre’ and ‘slightly bad’ levels between EAP and
YAP (P < 0.0001).
Satisfaction with daily life
Another target of asthma treatment according to the
guidelines for treatment is to allow patients to live
the same life as healthy people. In this context, ‘satisfac-
tion with daily life’ was used in the questionnaires as an
indicator. Subjects were asked to answer the question
by choosing one of five options (‘very satisfied’, ‘fairly
satisfied’, ‘mediocre’, ‘slightly unsatisfied’ and ‘very
unsatisfied’). For EAP, responses of ‘very satisfied’ and
‘fairly satisfied’ were recorded in 14.2 and 63.5% of
Table 2 Asthma attacks during the 2 weeks prior to answering the questionnaires
EAP YAP P
No. patients 1084 2116
Percentage without attacks (%) 51.0 58.6 0.0001
Subjective evaluation of asthma
Very good (%) 16.7 18.4 0.2650
Fairly good (%) 34.5 34.9 0.8123
Mediocre (%) 33.9 25.4 0.0001
Slightly bad (%) 10.6 17.1 0.0001
Bad (%) 2.9 3.6 0.4500
Data show the percentage of subjects without asthma attacks and subjective evaluation  of asthma during the 2 weeks prior to answering the
questionnaire. Although significantly fewer cases without attacks were found in elderly asthmatic patients (EAP) than young asthmatic patients (YAP),
subjective evaluations of asthma were better in EAP than in YAP.
Fig. 1 Average of the peak expiratory flow rate (PEF) value, as
a percentage of predicted PEF values (%PEF). Data are the
mean±
 
SD. (
 

 
), %PEF in young asthma patients (YAP) in the
morning and at night; (
 

 
), %PEF in eldery asthma patients (EAP)
in the morning and at night. Significant differences were seen
between the two groups (*P < 0.0001).
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respondents, respectively. Responses of ‘mediocre’, ‘very
unsatisfied’ or ‘slightly unsatisfied’ were cited by 10.8,
6.6 and 0.6% of subjects, respectively. There was a
significantly higher percentage of responses at the
level of ‘fairly satisfied’ (
 
P
 
 < 0.0001) and a signifi-
cantly lower percentage of ‘very unsatisfied’ or ‘medi-
ocre’ (
 
P
 
 < 0.0001) for EAP than for YAP (Table 3).
 
Asthma-related symptoms during the 2 weeks 
prior to answering the questionnaires
 
According to the guidelines, it is also important to
eliminate asthma-related symptoms, such as coughing
and a sense of dyspnea, and to enable satisfactory sleep
at night, as well as preventing asthma attacks. Based on
the questionnaire results, the occurrence of a variety of
asthma-related symptoms occurring early in the morn-
ing, at night and during sleep was examined. With
regard to symptoms early in the morning and at night,
a significant difference was found in the incidence of
sputum early in the morning (
 
P
 
 = 0.0005) and in the
incidence of chest oppression at night (
 
P
 
 = 0.0003)
between the two groups (Table 4). While patients were
sleeping, there were no differences in asthma-related
symptoms (Table 4).
 
Emergency events related to asthma attacks
 
Another obvious objective is to prevent death caused by
asthma attacks, as stated in the guidelines. Based on
 
Table 4
 
Asthma-related symptoms during the early morning, at night and during sleep
EAP (
 
n
 
 = 1084) YAP (
 
n
 
 = 2116)
 
P
 
Symptoms during the early morning (%) 56.8 53.7 0.2409
Sense of dyspnea (%) 9.5 9.6 0.8805
Wheezing (%) 11.9 13.0 0.3623
Chest oppression (%) 10.5 12.8 0.0608
Sputum (%) 29.7 23.9 0.0005
Coughing (%) 19.1 21.1 0.1664
Symptoms at night (%) 41.9 38.6 0.0603
Sense of dyspnea (%) 5.2 6.4 0.1646
Wheezing (%) 7.3 9.6 0.0250
Chest oppression (%) 6.0 9.7 0.0003
Sputum (%) 11.4 10.0 0.2250
Coughing (%) 9.8 11.8 0.0930
Symptoms during sleep (%) 32.4 29.7 0.1101
Impossible to sleep due to dyspnea (%) 2.1 2.6 0.4608
Too painful to sleep due to dyspnea (%) 6.0 7.3 0.1500
Woke up in night due to chest oppression (%) 11.2 13.9 0.0460
 
Asthma-related symptoms during the 2 weeks prior to answering the questionnaires are shown. With regard to symptoms during the early
morning and at night, significant differences were found in the incidence of both sputum in the early morning and chest oppression at night
between elderly asthmatic patients (EAP) and young asthmatic patients (YAP).
 
Table 3
 
Satisfaction with daily life
EAP YAP
 
P
 
No. patients 1084 2116
Satisfaction with daily life
Very satisfied (%) 14.2 13.0 0.3612
Fairly satisfied (%) 63.5 54.9 0.0001
Mediocre (%) 10.8 17.4 0.0001
Fairly satisfied (%) 6.6 11.6 0.0001
Very satisfied (%) 0.6 1.8 0.0153
 
Subjects were asked to answer the question regarding satisfaction with daily life by choosing one of the five answers given above. Significantly
better satisfaction with daily life was found in elderly asthmatic patients (EAP) compared with young asthmatic patients (YAP).
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the results of the questionnaires, the emergency events
experienced by the patients, which included ambulance
use, visits to the emergency room and hospitalization
(possibly associated with death from asthma), uncon-
sciousness during an asthma attack, management using
a respirator (often directly leading to asthma-induced
death) and AIA attacks (known to cause severe attacks
and death), were examined. Subjects were asked to
answer ‘yes’ or ‘no’ to the following five questions:
1. Have you ever had a respirator due to an asthma attack?
2. Have you ever been unconscious due to an asthma
attack?
3. Have you ever been hospitalized due to asthma?
4. Have you ever been taken by ambulance or visited an
emergency room due to an attack?
5. Have you ever had an attack induced by anti-
inflammatory drugs, including painkillers, antipyretics or
cold medicine?
Figure 2 shows the results of the responses to these
questions. Among the EAP respondents, 32.0% had
visited or used an emergency room or ambulance, which
was significantly (P < 0.0001) fewer than YAP respond-
ents (43.6%). Furthermore, 49.9% of EAP reported hos-
pitalization due to asthma, which was significantly
(P < 0.0001) greater than YAP (43.8%). There was no
difference in the incidence of patients who had lost con-
sciousness due to an asthma attack or had managed
their asthma with a respirator (Fig. 2). In the EAP group,
6.8% of patients had experienced an attack after taking
anti-inflammatory drugs, compared with 9.9% in the YAP
group.
Medication
Patients’ drug use was examined based on the question-
naire results from their physicians (Fig. 3). Sustained-
release theophylline was used very frequently in both
groups, but a significantly higher incidence of use of
sustained-release theophylline was found in EAP com-
pared with YAP (P < 0.0001). Looking at the rates of
use of inhaled steroids, oral steroids and inhaled
Fig. 2 Rates of visits to an emergency room (ER) or the use of an ambulance, hospitalization due to asthma, loss of consciousness
due to asthma attacks and management by a respirator. (
 

 
), young asthma patients (YAP); (
 

 
), eldery asthma patients (EAP).
Significant differences were seen between the two groups (*P < 0.0001). AIA, aspirin-induced asthma attack.
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β2-adrenergic agonists in the EAP group, there were
also significant differences compared with the YAP
group (all P < 0.0001), as shown in Fig. 3. However,
there was no significant difference in the rate of use of
antileukotrienes or anti-allergics.
DISCUSSION
In this questionnaire-based investigation, information
was obtained on 2798 cases treated by respiratory
physicians and 426 cases treated by general physicians.
This means that the majority of patients were from
specialist institutions and that the results of the present
study may indicate the status of patients managed by
specialists more closely than that of patients managed
by non-specialists.
In comparing EAP and YAP, there was no significant
difference in the duration of asthma between the two
groups, which corresponded with the report that high
age-onset (after 40 years) asthmatic patients constituted
the majority of cases in elderly (over 65 years) subjects
with bronchial asthma.7 Although there were variations in
terms of the classification of bronchial asthma, patients
in the present study were divided into atopic-, mixed- and
infectious-type disease groups. The percentage of infec-
tious-type disease in EAP was greater than that in YAP,
which is consistent with data presented in previous
reports.7–10 The present investigation found that the rate
of use of peak flow meters was 25.8% in EAP, which was
significantly lower than that in YAP. However, it should be
noted that, even in YAP, only 38.3% of subjects used a
peak flow meter. This indicates that this instrument is not
widely used in Niigata Prefecture, Japan, and that patient
education by physicians for this treatment is not well
carried out, although the guidelines strongly recommend
it. The advantage of using a peak flow meter for patients
was probably not accepted due to both its cost and com-
plexity, although the questionnaire did not address this.
With their ability to enable daily evaluation of objective
respiratory function, the use of peak flow meters should
be more widely introduced in the future.
In assessing PEF, the average %PEF in EAP was under
80% (73.1% in the morning and 76.7% at night, which is
comparatively favorable but significantly lower than the
figures for YAP; P < 0.0001). This result was not due to
more severe remodeling of the bronchial wall, but due to
Fig. 3 Summary of the drugs used to control asthmatic patients based on questionnaire results from physicians in charge. (),
young asthma patients (YAP); (), eldery asthma patients (EAP). Significant differences were seen between the two groups
(*P < 0.0001). SR theophylline, sustained-release theophylline; β2 stimulators, β2-adrenergic agonists; anti-LT, anti-leukotriene
compounds.
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a larger population of cases of severe asthma and less
pulmonary function in the EAP group compared with the
YAP group, because no significant difference was found
in the duration of asthma, when the remodeling process
does not depend upon aging. The differences in %PEF
and the percentage of patients without attacks during the
2 weeks prior to answering the questionnaires clearly
showed that asthma control in EAP was poorer than in
YAP. Nevertheless, other subjective indicators of asthma
control, including subjective evaluation of asthma during
the 2 weeks and the degree of satisfaction with daily life,
were contrary. The tradition of stoicism or ‘extreme toler-
ance’ among the elderly in Japan may have influenced
these conflicting results. To avoid this, other objective
indicators, including an adequate anamnesis and ade-
quate education about self-evaluation of asthma control,
are required. These issues are discussed later.
As for preventing death from asthma, the question-
naires found that the patients had experienced ambulance
use, visits to the emergency room and hospitalization,
unconsciousness during an asthma attack, management
by a respirator and AIA attacks. The lower incidence of
ambulance use or visits to the emergency room and the
higher incidence of hospitalization in EAP are very impor-
tant. Because EAP are more prone to other diseases,
including cerebrovascular or cardiovascular diseases, it
is well understood that hospitalization occurs more often
in EAP than in YAP. However, this discrepancy, may be
partly due to the ‘extreme tolerance’ mentioned above,
resulting in both incomplete self-relief treatment against
asthma attacks and a consequent delay in administering
medication during an attack. In this respect, adequate
education regarding asthmatic attacks will be also
required for EAP. In addition, the incidence of an AIA in
the EAP group, according to the results of the present
study, was lower than in the YAP group, but this difference
was not statistically significant, indicating that diagnosis
of AIA by anamnesis is not as precise as reported
previously
 
11
 
 because of the 10% or greater incidence
of AIA in all asthmatic patients. There may be many
patients (incorrectly) not diagnosed as having AIA,
especially in EAP.
In the present study, some patterns of drug treatment
of asthma in EAP were observed. Lower frequency of use
of inhaled steroids and 
 
β
 
2
 
-adrenergic agonists was
obvious in the EAP group. Difficulty inhaling medicines
and their consequent persistance in oral the and throat
cavity in EAP resulted in a lower use of these drugs. Espe-
cially with inhalation steroids, any steroid remaining in
the oral cavity can cause oral and throat candidiasis and
hoarseness, resulting in decreased compliance with
steroid inhalation. In the case of the inhalation of
 
β
 
2
 
-adrenergic agonists, their decreased use among EAP
is thought to be related to a higher incidence of side-
effects, including palpitation and tremor of the extrem-
ities, and a less effective bronchial response12 than in
YAP. The increased use of oral steroid and of sustained-
released theophylline in EAP partly indicates that these
drugs were probably substitutes for inhalation; the
former, in particular, was used instead of inhalation
steroids. However, the complications associated with
systemic steroid administration, including osteoporosis
and diabetes mellitus, are known to appear more often
and severely in elderly people. It is necessary to reduce
the dose of oral steroid in the treatment of EAP using
both combinations of other asthma medicines and well-
established programs for EAP education. In contrast, the
high incidence of the use of sustained-released theophyl-
line has been one of the characteristics of drug treatment
of asthma in Japan. However, the complications associ-
ated with theophylline, including the narrow range of
effective serum levels, more interactions with other
drugs and a lesser dilator action on the bronchi than
β2-adrenergic agonists, mean it is not usually used in
the USA and European countries.13 It has been reported
that theophylline aided the construction of respiratory
muscles, increased tolerance of the long-term use of
those muscles and stimulated the central nerve respons-
ible for respiration.14 Moreover, an anti-inflammatory
action for asthma (for activated eosinophils) was recently
observed.15,16 It was reported that the combination of a
moderate dose of inhaled steroid and sustained-released
theophylline was more effective than a high dose of
inhaled steroid.17 Thus, sustained-released theophylline
should be used more frequently worldwide.
Because the mean lifespan is increasing and the per-
centage of elderly people in the population as a whole
is also increasing, the management of elderly patients is
expected to become more important in future medicine.
In the present study, based on questionnaires given to
3224 asthmatic patients in Niigata Prefecture, the char-
acteristics, management and circumstances of EAP were
observed. The discrepancy between objective and sub-
jective evaluation of asthma control, the incidence of the
use of both inhaled and oral steroids and the low inci-
dence of the use of peak flow meters are problematic.
The differences in the attitudes of asthma patients towards
freeing themselves of the disease are very important.
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However, it is often difficult for every physician to manage
asthma treatment effectively when the strategy in the
guidelines cannot be applied to EAP. Thus, based on suf-
ficient consideration of EAP-related problems, adequate
education and careful management of asthma among
EAP are required and the accumulation of these steps will
result in the achievement of the guidelines’ final goals.
REFERENCES
1 Isoaho R, Puolijoki H, Huhti E, Kivela SL, Tala E. Preva-
lence of asthma in elderly Fins. J. Clin. Epidemiol. 1994;
47: 1109–18.
2 Parameswaran K, Hildroth AJ, Chadha D, Keaney NP,
Taylor JK, Bansal SK. Asthma in elderly: Underperceived,
underdiagnosed and underrated. A community survey.
Respir. Med. 1998; 92: 573–7.
3 Nejjari C, Tessier JE, Letenncur L, Dartigues JF,
Barberger Gateau P, Salamon R. Prevalence of self-
reported asthma symptoms in a French elderly sample.
Respir. Med. 1996; 90: 401–8.
4 Quadrelli SA, Roncoroni A. Features of asthma in the
elderly. J. Asthma 2001; 38: 377–89.
5 National Asthma Education and Prevention Program.
Guidelines for the Diagnosis and Management of Asthma,
Expert Panel Report 2. Bethesda: National Institutes of
Health. 1997.
6 Makino S, Furusho K, Miyamoto T, Ohta K. Asthma
Prevention and Management Guidelines 1998, Japan
(JGL): English version. Int. Arch. Allergy Immunol. 2000;
121: 1–78.
7 Quadrelli SA, Roncoroni AJ. Is asthma in elderly really
different? Respiration 1998; 65: 347–53.
8 Enright PL, Burchette RJ, Peters JA, Lebowitz MD,
McDonnell WF, Abbey DE. Peak flow lability: Association
with asthma and spirometry in an older cohort. Chest
1997; 112: 895–901.
9 Barbee RA, Brown WG, Kaltenborn W, Halonen M.
Allergen skin-test reactivity in a community population
sample: Correlation with age, histamine skin reactions
and total serum immunoglobulin E. J. Allergy Clin.
Immunol. 1991; 68: 15–9.
10 Geraghty R, Foster C, Black D, Roe S. Bronchodiilator
response to nebulized salbutamol in elderly patients with
stable chronic airflow limitation. Respir. Med. 1993; 87:
375–8.
11 Spector SL, Wangaard CH, Farr RS. Aspirin and concom-
itant idiosyncrasies in adult asthmatic patients. J. Allergy
Clin. Immunol. 1979; 64: 500–6.
12 Connolly MJ, Crowley JJ, Nielson CP, Charan NB, Vestal
RE. Peripheral mononuclear leucocyte beta adreno-
ceptors and non-specific bronchial responsiveness to
methacholine in young and elderly normal subjects and
asthmatic patients. Thorax 1994; 49: 26–32.
13 Blasis L, Ernst P, Boivin JF, Suissa S. Inhaled cortico-
steroids and the prevention of readmission to hospital for
asthma. Am. J. Respir. Crit. Care Med. 1998; 158:
126–32.
14 Murciano D, Aubier M, Lecocguic Y, Pariente R Effects of
theophylline on diaphragmatic strength and fatigue in
patients with chronic obstructive pulmonary disease.
N. Engl. J. Med. 1984; 311: 349–53.
15 Sagara H, Fukuda T, Okada T, Ishikawa A, Makino S.
Thophylline at therapeutic concentration suppressed
PAF-induced upregulation of Mac-1 on human eosi-
nophils. Clin. Exp. Allergy 1996; 26: 16–21.
16 Ohta K, Sawamoto S, Nakajima M et al. The prolonged
survival of human eosinophils with interleukin-5 and its
inhibition by theophylline via apoptosis. Clin. Exp. Allergy
1996; 26: 10–15.
17 Evans DJ, Taylor DA, Zetterstrom O, Churg KF,
O’Connor BJ, Barnes PJ. A comparison of low-dose
inhaled budesonide plus theophylllin and high-dose
inhaled budesonide for moderate asthma. N. Engl. J.
Med. 1997; 337: 1412–18.
